Open AccessA PD-L1 Aptamer Selected by Loss-Gain Cell-SELEX Conjugated with Paclitaxel for Treating Triple-Negative Breast Cancer
Author(s) -
Xiaoqiu Wu,
Fangfei Li,
Yongshu Li,
Yuanyuan Yu,
Chao Liang,
BaoTing Zhang,
Chuanzong Zhao,
Aiping Lü,
Ge Zhang
Publication year - 2020
Publication title -
medical science monitor
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.636
H-Index - 85
eISSN - 1643-3750
pISSN - 1234-1010
DOI - 10.12659/msm.925583
Subject(s) - aptamer , flow cytometry , triple negative breast cancer , systematic evolution of ligands by exponential enrichment , cancer research , paclitaxel , microbiology and biotechnology , chemistry , biology , breast cancer , cancer , biochemistry , rna , genetics , gene
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom